PerkinElmer Acquires Spectral Genomics, Inc.
Molecular Karyotyping Technology Expected to Drive Advances in Prenatal and Neonatal Research and Disease Detection
03-May-2006 -
PerkinElmer, Inc. announced the acquisition of the assets of Spectral Genomics, Inc., a company focussing on molecular karyotyping technology used to evaluate chromosomal abnormalities. Terms of the deal were not disclosed.
Spectral Genomics' array products and analysis software help ...
biotechnology
genetic diseases
genetic disorders
+2